Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder
- 1 March 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (3) , 315-317
- https://doi.org/10.1016/0277-5379(84)90075-0
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II studyEuropean Journal of Cancer and Clinical Oncology, 1982
- PHASE-II EVALUATION OF VM-26 IN PATIENTS WITH METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE URINARY-TRACT - AN EASTERN COOPERATIVE ONCOLOGY GROUP-STUDY1982
- Cis-dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasmsCancer, 1980
- Cis-Diamminedichloride Platinum II in the Treatment of Abvanced Bladder CancerJournal of Urology, 1980
- Chemotherapy of Metastatic Bladder CancerCancer, 1980
- Cis-Diamminebichloroplatinum as a Therapeutic Agent in Metastatic Transitional Cell CarcinomaJournal of Urology, 1980
- Studies of cross-resistance, synergistic combinations and blocking of activity of platinum derivativesBiochimie, 1978
- Single-Drug Chemotherapy of Bladder Cancer with Adriamycin, VM-26 or BleomycinEuropean Urology, 1976